Adverse Reactions to Immunotherapy Can Appear After a Year
Clinicians should be on the lookout for immune-related adverse reactions (irAEs) even after patients have been receiving anti–programmed cell death […]
» Read moreHome »
A letter published today by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New […] Melanoma skin cancer is the fifth most common cancer in the UK, with around 16,200 people diagnosed each year. And […] Eye cancer, as the name suggests begins in the eye. The eye is composed of various smaller structures each of […] (HealthDay)—Among people with skin of color, ultraviolet (UV) exposure may not be an important risk factor for melanoma, according to […] (HealthDay)—From 2001 to 2016, the use of Mohs surgery for melanoma increased more than threefold, according to a study published […] Nuclear medicine imaging with PET/CT can monitor the effectiveness of immunotherapy treatment for metastatic melanoma and predict outcome. In this […] A pair of studies led by University of North Carolina Lineberger Comprehensive Cancer Center researchers could aid in improved diagnosis […] In 2015, the United States Food and Drug Administration (FDA) approved the use of talimogene laherparepvec (TVEC) for the treatment […] Adoptive cell transfer (ACT) is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable […]
Research shows melanoma rates in Utah outpace that of the rest of the U.S.
New link between high testosterone in men and increased risk of melanoma
What is eye cancer?
UV exposure not linked to risk for melanoma in skin of color
2001 to 2016 saw large increase in Mohs surgery for melanoma
Nuclear medicine imaging monitors effectiveness of therapy for melanoma patients
New studies aim to improve melanoma diagnosis
Modified herpes virus effective against late-stage melanoma
Triple combination cancer immunotherapy improves outcomes in preclinical melanoma model
